Cited by 1,802Cancer Cells and MetastasisCancer Immunotherapy and BiomarkersCancer, Hypoxia, and Metabolism

The DOI matches its Crossref record; 122 of the 124 references it cites were found in a registry or an index.

Tumor microenvironment and therapeutic response

Wu, Ting, Dai, Yun·2017·Cancer Letters

DOI 10.1016/j.canlet.2016.01.043

Open this paper in CoChat — free account

Abstract

The tumor microenvironment significantly influences therapeutic response and clinical outcome. Microenvironment-mediated drug resistance can be induced by soluble factors secreted by tumor or stromal cells. The adhesion of tumor cells to stromal fibroblasts or to components of the extracellular matrix can also blunt therapeutic response. Microenvironment-targeted therapy strategies include inhibition of the extracellular ligand-receptor interactions and downstream pathways. Immune cells can both improve and obstruct therapeutic efficacy and may vary in their activation status within the tumor microenvironment; thus, re-programme of the immune response would be substantially more beneficial. The development of rational drug combinations that can simultaneously target tumor cells and the microenvironment may represent a solution to overcome therapeutic resistance.

Integrity signals

Registry

Crossref · 10.1016/j.canlet.2016.01.043

Cites

122 of 122 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Microenvironmental regulation of tumor progression and metastasis
Quail, D. F., & Joyce, J. A. (2013) · Nature Medicine · doi:10.1038/nm.3394 · Cited by 7,994
Macrophage Diversity Enhances Tumor Progression and Metastasis
Qian, B., & Pollard, J. W. (2010) · Cell · doi:10.1016/j.cell.2010.03.014 · Cited by 5,338
Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
Hanahan, D., & Coussens, L. M. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.02.022 · Cited by 4,632
Fibroblasts in cancer
Kalluri, R., & Zeisberg, M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1877 · Cited by 4,538
Stromal Fibroblasts Present in Invasive Human Breast Carcinomas Promote Tumor Growth and Angiogenesis through Elevated SDF-1/CXCL12 Secretion
Orimo, A., Gupta, P. B., Sgroi, D. C., Arenzana-Seisdedos, F., Delaunay, T., Naeem, R., Carey, V. J., Richardson, A. L., & Weinberg, R. A. (2005) · Cell · doi:10.1016/j.cell.2005.02.034 · Cited by 3,759
Coordinated regulation of myeloid cells by tumours
Gabrilovich, D. I., Ostrand-Rosenberg, S., & Bronte, V. (2012) · Nature Reviews Immunology · doi:10.1038/nri3175 · Cited by 3,544
Immunogenic Cell Death in Cancer Therapy
Kroemer, G., Galluzzi, L., Kepp, O., & Zitvogel, L. (2013) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032712-100008 · Cited by 3,303
CSF-1R inhibition alters macrophage polarization and blocks glioma progression
Pyonteck, S. M., Akkari, L., Schuhmacher, A. J., Bowman, R. L., Sevenich, L., Quail, D. F., Olson, O. C., Quick, M. L., Huse, J. T., Teijeiro, V., et al. (2013) · Nature Medicine · doi:10.1038/nm.3337 · Cited by 2,463
Macrophage plasticity and polarization in tissue repair and remodelling
Mantovani, A., Biswas, S. K., Galdiero, M. R., Sica, A., & Locati, M. (2013) · The Journal of Pathology · doi:10.1002/path.4133 · Cited by 2,384

Flagged first, then by citations

Show all 124 references

2 of the 124 references couldn’t be matched to a known paper.

Sorted by citations

Items 101–200 of 1,000

Nanoparticles mediated tumor microenvironment modulation: current advances and applications
Raju, G. S. R., Pavitra, E., Varaprasad, G. L., Bandaru, S. S., Nagaraju, G. P., Farran, B., Huh, Y. S., & Han, Y. (2022) · Journal of Nanobiotechnology · doi:10.1186/s12951-022-01476-9 · Cited by 101
Gold nanoparticle-directed autophagy intervention for antitumor immunotherapy via inhibiting tumor-associated macrophage M2 polarization
Zhang, S., Xie, F., Li, K., Zhang, H., Yin, Y., Yu, Y., Lu, G., Zhang, S., Wei, Y., Xu, K., et al. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2022.02.008 · Cited by 95
Self-triggered thermoelectric nanoheterojunction for cancer catalytic and immunotherapy
Xue, Y., Kang, Y., Dong, J., Li, R., Ye, J., Fan, Y., Han, J., Yu, J., Ni, G., Ji, X., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-40954-y · Cited by 95
Enhanced histone H3 acetylation of the PD-L1 promoter via the COP1/c-Jun/HDAC3 axis is required for PD-L1 expression in drug-resistant cancer cells
Wang, H., Fu, C., Du, J., Wang, H., He, R., Yin, X., Li, H., Li, X., Wang, H., Li, K., et al. (2020) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-020-1536-x · Cited by 94
Circular RNAs in drug resistant tumors
Hua, X., Sun, Y., Chen, J., Wu, Y., Sha, J., Han, S., & Zhu, X. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109233 · Cited by 90
TP63 links chromatin remodeling and enhancer reprogramming to epidermal differentiation and squamous cell carcinoma development
Yi, M., Tan, Y., Wang, L., Cai, J., Li, X., Zeng, Z., Xiong, W., Li, X., Li, X., Tan, P., et al. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03539-2 · Cited by 89
Immunotherapy resistance in non-small-cell lung cancer: From mechanism to clinical strategies
Zhou, S., & Yang, H. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1129465 · Cited by 98
Advances in Understanding the Roles of CD244 (SLAMF4) in Immune Regulation and Associated Diseases
Sun, L., Gang, X., Li, Z., Zhao, X. Y., Zhou, T., Zhang, S., & Wang, G. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.648182 · Cited by 90
Single-Cell RNA Sequencing in Lung Cancer: Revealing Phenotype Shaping of Stromal Cells in the Microenvironment
Zhang, J., Song, C., Tian, Y. F., & Yang, X. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2021.802080 · Cited by 89
A patient-specific lung cancer assembloid model with heterogeneous tumor microenvironments
Zhang, Y., Hu, Q., Pei, Y., Luo, H., Wang, Z., Xu, X., Zhang, Q. H., Dai, J., Wang, Q., Fan, Z., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-47737-z · Cited by 92
Nano-Medicine for Thrombosis: A Precise Diagnosis and Treatment Strategy
Su, M., Dai, Q., Chen, C., Zeng, Y., Chu, C., & Liu, G. (2020) · Nano-Micro Letters · doi:10.1007/s40820-020-00434-0 · Cited by 85
ITGA5 is a prognostic biomarker and correlated with immune infiltration in gastrointestinal tumors
Zhu, H. H., Wang, G., Zhu, H., & Xu, A. (2021) · BMC Cancer · doi:10.1186/s12885-021-07996-1 · Cited by 84
Recent Metabolomics Analysis in Tumor Metabolism Reprogramming
Han, J., Li, Q., Chen, Y., & Yang, Y. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.763902 · Cited by 90
Edge modification facilitated heterogenization and exfoliation of two-dimensional nanomaterials for cancer catalytic therapy
Chen, L., Mao, Z., Wang, Y., Kang, Y., Wang, Y., Mei, L., & Ji, X. (2022) · Science Advances · doi:10.1126/sciadv.abo7372 · Cited by 84
The function of natural compounds in important anticancer mechanisms
Nan, Y., Su, H., Zhou, B., & Liu, S. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2022.1049888 · Cited by 88
The Promise of Nanoparticles-Based Radiotherapy in Cancer Treatment
Haque, M., Shakil, M. S., & Mahmud, K. M. (2023) · Cancers · doi:10.3390/cancers15061892 · Cited by 88
Tumor Microenvironment Immunosuppression: A Roadblock to CAR T-Cell Advancement in Solid Tumors
Cheever, A., Townsend, M. H., & O'Neill, K. L. (2022) · Cells · doi:10.3390/cells11223626 · Cited by 94
Metal ions and nanometallic materials in antitumor immunity: Function, application, and perspective
Shen, F., Fang, Y., Wu, Y., Zhou, M., Shen, J., & Fan, X. (2023) · Journal of Nanobiotechnology · doi:10.1186/s12951-023-01771-z · Cited by 86
Overcoming acquired resistance to cancer immune checkpoint therapy: potential strategies based on molecular mechanisms
Wang, B., Yin, H., Zhang, Y., Zhao, Q., Wang, H., Wei, J., Meng, L., Xin, Y., & Jiang, X. M. (2023) · Cell & Bioscience · doi:10.1186/s13578-023-01073-9 · Cited by 85
Nanoparticle-mediated cancer cell therapy: basic science to clinical applications
Verma, J., Warsame, C., Seenivasagam, R. K., Katiyar, N. K., Aleem, E. A., & Goel, S. (2023) · Cancer and Metastasis Reviews · doi:10.1007/s10555-023-10086-2 · Cited by 84
Photodynamic Modulation of Endoplasmic Reticulum and Mitochondria Network Boosted Cancer Immunotherapy
Wang, X., Qian, J., Yang, Z., Song, Y., Pan, W., Ye, Y., Qin, X., Yan, X., Huang, X., Wang, X., et al. (2023) · Advanced Materials · doi:10.1002/adma.202310964 · Cited by 80
The interactions and communications in tumor resistance to radiotherapy: Therapy perspectives
Ashrafizadeh, M., Farhood, B., Musa, A. E., Taeb, S., & Najafi, M. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106807 · Cited by 79
The systemic immune-inflammation index predicts prognosis in intrahepatic cholangiocarcinoma: an international multi-institutional analysis
Tsilimigras, D. I., Moris, D., Mehta, R., Paredes, A. Z., Sahara, K., Guglielmi, A., Aldrighetti, L. A., Weiss, M. J., Bauer, T. W., Alexandrescu, S. T., et al. (2020) · HPB · doi:10.1016/j.hpb.2020.03.011 · Cited by 77
Connecting METTL3 and intratumoural CD33+ MDSCs in predicting clinical outcome in cervical cancer
Ni, H.-H., Zhang, L., Huang, H., Dai, S., & Li, J. (2020) · Journal of Translational Medicine · doi:10.1186/s12967-020-02553-z · Cited by 77
Tumour Microenvironment Stress Promotes the Development of Drug Resistance
Seebacher, N. A., Krchniaková, M., Stacy, A. E., Skoda, J., & Jansson, P. J. (2021) · Antioxidants · doi:10.3390/antiox10111801 · Cited by 84
Monofunctional Platinum(II) Anticancer Agents
Jin, S., Guo, Y., Guo, Z., & Wang, X. (2021) · Pharmaceuticals · doi:10.3390/ph14020133 · Cited by 78
Chronic stress in solid tumor development: from mechanisms to interventions
Yan, J., Chen, Y., Luo, M., Hu, X., Li, H., Liu, Q., & Zou, Z. (2023) · Journal of Biomedical Science · doi:10.1186/s12929-023-00903-9 · Cited by 89
The role of glutamate receptors in the regulation of the tumor microenvironment
Koda, S., Hu, J., Ju, X., Sun, G., Shao, S., Tang, R., Zheng, K., & Yan, J. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1123841 · Cited by 81
Role of stress in the pathogenesis of cancer (Review)
Lempesis, I. G., Georgakopoulou, V., Papalexis, P., Chrousos, G. P., & Spandidos, D. A. (2023) · International Journal of Oncology · doi:10.3892/ijo.2023.5572 · Cited by 82
Complex interplay between tumor microenvironment and cancer therapy
Shen, M., & Kang, Y. (2018) · Frontiers of Medicine · doi:10.1007/s11684-018-0663-7 · Cited by 76
Ionizing radiation effects on the tumor microenvironment
Portella, L., & Scala, S. (2019) · Seminars in Oncology · doi:10.1053/j.seminoncol.2019.07.003 · Cited by 78
PAI-1 derived from cancer-associated fibroblasts in esophageal squamous cell carcinoma promotes the invasion of cancer cells and the migration of macrophages
Sakamoto, H., Koma, Y., Higashino, N., Kodama, T., Tanigawa, K., Shimizu, M., Fujikawa, M., Nishio, M., Shigeoka, M., Kakeji, Y., et al. (2020) · Laboratory Investigation · doi:10.1038/s41374-020-00512-2 · Cited by 75
Phospholipase A2 Drives Tumorigenesis and Cancer Aggressiveness through Its Interaction with Annexin A1
Vecchi, L., Araújo, T. G., Azevedo, F. V. P. D. V., Mota, S. T. S., Rodrigues, V. D. M., Ribeiro, M. A., & Goulart, L. R. (2021) · Cells · doi:10.3390/cells10061472 · Cited by 75
Regulation of tumor immunity and immunotherapy by the tumor collagen extracellular matrix
Flies, D. B., Langermann, S., Jensen, C., Karsdal, M. A., & Willumsen, N. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1199513 · Cited by 79
Cancer-associated fibroblasts-derived exosomes promote lung cancer progression by OIP5-AS1/ miR-142-5p/ PD-L1 axis
Jiang, Y., Wang, K., Lu, X., Wang, Y., & Chen, J. (2021) · Molecular Immunology · doi:10.1016/j.molimm.2021.10.002 · Cited by 76
Alleviating the hypoxic tumor microenvironment with MnO2-coated CeO2 nanoplatform for magnetic resonance imaging guided radiotherapy
Pi, F., Deng, X., Xue, Q., Zheng, L., Liu, H., Yang, F., & Chen, T. (2023) · Journal of Nanobiotechnology · doi:10.1186/s12951-023-01850-1 · Cited by 76
Roles of NK Cell Receptors 2B4 (CD244), CS1 (CD319), and LLT1 (CLEC2D) in Cancer
Buller, C. W., Mathew, P. A., & Mathew, S. O. (2020) · Cancers · doi:10.3390/cancers12071755 · Cited by 76
Neutrophil Extracellular Traps in Cancer Therapy Resistance
Shahzad, M. H., Feng, L., Su, X., Brassard, A., Dhoparee‐Doomah, I., Ferri, L. E., Spicer, J. D., & Cools‐Lartigue, J. (2022) · Cancers · doi:10.3390/cancers14051359 · Cited by 76
Nucleic Acid-Based Approaches for Tumor Therapy
Hager, S., Fittler, F. J., Wagner, E., & Bros, M. (2020) · Cells · doi:10.3390/cells9092061 · Cited by 78
CXCL12 Signaling in the Tumor Microenvironment
Portella, L., Bello, A. M., & Scala, S. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-62658-7_5 · Cited by 72
Clinical relevance of tumor microenvironment: immune cells, vessels, and mouse models
Katsuta, E., Rashid, O. M., & Takabe, K. (2020) · Human Cell · doi:10.1007/s13577-020-00380-4 · Cited by 72
HIF-2α-targeted interventional chemoembolization multifunctional microspheres for effective elimination of hepatocellular carcinoma
Chen, M., Shu, G., Lv, X., Xu, X., Lu, C., Qiao, E., Fang, S., Shen, L., Zhang, N., Wang, J., et al. (2022) · Biomaterials · doi:10.1016/j.biomaterials.2022.121512 · Cited by 71
TRAILblazing Strategies for Cancer Treatment
Kretz, A.-L., Trauzold, A., Hillenbrand, A., Knippschild, U., Henne‐Bruns, D., von Karstedt, S., & Lemke, J. (2019) · Cancers · doi:10.3390/cancers11040456 · Cited by 71
Targeting the tumour immune microenvironment for cancer therapy in human gastrointestinal malignancies
Zhang, Y., Jiang, X., Zhang, N., Chen, M., Wang, H., & Zhu, D. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.05.017 · Cited by 69
Identification of PIEZO1 as a potential prognostic marker in gliomas
Zhou, W., Liu, X., van Wijnbergen, J. W., Yuan, L., Liu, Y., Zhang, C., & Jia, W. (2020) · Scientific Reports · doi:10.1038/s41598-020-72886-8 · Cited by 74
Remodeling tumor microenvironment with natural products to overcome drug resistance
Zhang, W., Li, S., Li, C., Li, T., & Huang, Y. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1051998 · Cited by 74
Targeting NEDD8-activating enzyme for cancer therapy: developments, clinical trials, challenges and future research directions
Fu, D., & Wang, T. (2023) · Journal of Hematology & Oncology · doi:10.1186/s13045-023-01485-7 · Cited by 70
Enhancing radiotherapy-induced anti-tumor immunity via nanoparticle-mediated STING agonist synergy
Zeng, Q., Liu, M., Wang, Z., Zhou, R., & Ai, K. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02366-y · Cited by 90
Cancer-Associated Fibroblasts in Mycosis Fungoides Promote Tumor Cell Migration and Drug Resistance through CXCL12/CXCR4
Aronovich, A., Moyal, L., Gorovitz, B., Amitay‐Laish, I., Naveh, H. P., Forer, Y., Maron, L., Knaneh, J., Ad‐El, D., Yaacobi, D. S., et al. (2020) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2020.06.034 · Cited by 70
Barrier permeation and improved nanomedicine delivery in tumor microenvironments
Liu, J., Zhang, J., Gao, Y., Jiang, Y., Guan, Z., Xie, Y., Hu, J., & Chen, J. (2023) · Cancer Letters · doi:10.1016/j.canlet.2023.216166 · Cited by 75
Role of Oral Bacteria in the Development of Oral Squamous Cell Carcinoma
Li, Q., Hu, Y., Zhou, X., Liu, S., Han, Q., & Cheng, L. (2020) · Cancers · doi:10.3390/cancers12102797 · Cited by 71
Oxygen-Deficient Tungsten Oxide (WO x ) Nanobelts with pH-Sensitive Degradation for Enhanced Sonodynamic Therapy of Cancer
Zhou, Y., Yang, N., Gong, F., Wang, Y., Yang, X., Dai, Y., Yu, Q., Wang, L., Chen, W., Zhuo, M., et al. (2022) · ACS Nano · doi:10.1021/acsnano.2c07903 · Cited by 73
Self-citation
Single‐cell RNA sequencing reveals cellular and molecular reprograming landscape of gliomas and lung cancer brain metastases
Sun, H., Li, L., Lao, I. W., Li, X., Xu, B., Cao, Y., & Jin, W. (2022) · Clinical and Translational Medicine · doi:10.1002/ctm2.1101 · Cited by 71
A novel cuproptosis-related prognostic lncRNA signature and lncRNA MIR31HG/miR-193a-3p/TNFRSF21 regulatory axis in lung adenocarcinoma
Mo, X., Hu, D., Yang, P., Li, Y., Bashir, S., Nai, A., Ma, F., Jia, G., & Xu, M. Q. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.927706 · Cited by 68
Effects of microenvironment in osteosarcoma on chemoresistance and the promise of immunotherapy as an osteosarcoma therapeutic modality
Yu, L., Zhang, J., & Li, Y. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.871076 · Cited by 68
GABAergic signaling as a potential therapeutic target in cancers
Yang, Y., Ren, L., Li, W., Zhang, Y., Zhang, S., Ge, B., Yang, H., Du, G., Tang, B., Wang, H., et al. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114410 · Cited by 66
Single-cell transcriptome analysis indicates fatty acid metabolism-mediated metastasis and immunosuppression in male breast cancer
Sun, H., Zhang, L., Wang, Z., Gu, D., Zhu, M., Cai, Y., Li, L., Tang, J., Huang, B., Bosco, B., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-41318-2 · Cited by 68
Cancer-associated fibroblasts promote the migration and invasion of gastric cancer cells via activating IL-17a/JAK2/STAT3 signaling
Zhang, J., Li, S., Zhao, Y., Ma, P., Cao, Y., Liu, C., Zhang, X., Wang, W., Chen, L., & Yin, L. (2020) · Annals of Translational Medicine · doi:10.21037/atm-20-4843 · Cited by 65
Identification of Immune Cell Infiltration and Immune-Related Genes in the Tumor Microenvironment of Glioblastomas
Huang, S., Song, Z., Zhang, T., He, X., Huang, K., Zhang, Q., Shen, J. G., & Pan, J. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.585034 · Cited by 65
Discovery and development of tumor glycolysis rate-limiting enzyme inhibitors
Sun, X., Peng, Y., Zhao, J., Xie, Z., Lei, X., & Tang, G. (2021) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2021.104891 · Cited by 70
The Application of Inorganic Nanoparticles in Molecular Targeted Cancer Therapy: EGFR Targeting
Sun, M., Wang, T., Li, L., Li, X., Zhai, Y., Zhang, J., & Li, W. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.702445 · Cited by 63
Moving beyond cisplatin resistance: mechanisms, challenges, and prospects for overcoming recurrence in clinical cancer therapy
Fu, R., Zhao, B., Chen, M., Fu, X., Zhang, Q., Cui, Y., Hu, X., & Zhou, W. (2023) · Medical Oncology · doi:10.1007/s12032-023-02237-w · Cited by 71
Cell Plasticity and Prostate Cancer: The Role of Epithelial–Mesenchymal Transition in Tumor Progression, Invasion, Metastasis and Cancer Therapy Resistance
Papanikolaou, S., Vourda, A., Syggelos, S. A., & Gyftopoulos, K. (2021) · Cancers · doi:10.3390/cancers13112795 · Cited by 67
Novel Tumor-Microenvironment-Based Sequential Catalytic Therapy by Fe(II)-Engineered Polydopamine Nanoparticles
Zhu, Y., Xin, N., Qiao, Z., Chen, S., Zeng, L., Zhang, Y., Wei, D., Sun, J., & Fan, H. (2019) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b17951 · Cited by 64
TUBA1C is a Prognostic Marker in Low-grade Glioma and Correlates with Immune Cell Infiltration in the Tumor Microenvironment
Zhu, H., Hu, X., Gu, L., Jian, Z., Li, L., Hu, S., Qiu, S., & Xiong, X. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.759953 · Cited by 62
Melanin-like nanoparticles: advances in surface modification and tumour photothermal therapy
Tian, L., Li, X., Ji, H., Yu, Q., Yang, M., Guo, L., Huang, L., & Gao, W. (2022) · Journal of Nanobiotechnology · doi:10.1186/s12951-022-01698-x · Cited by 63
Cancer‐associated fibroblasts–derived exosomes‐mediated transfer of LINC00355 regulates bladder cancer cell proliferation and invasion
Yan, L., Wang, P., Fang, W., & Liang, C. (2019) · Cell Biochemistry and Function · doi:10.1002/cbf.3462 · Cited by 63
Internally Responsive Nanomaterials for Activatable Multimodal Imaging of Cancer
Rosenkrans, Z. T., Ferreira, C. A., Ni, D., & Cai, W. (2020) · Advanced Healthcare Materials · doi:10.1002/adhm.202000690 · Cited by 62
Nucleus-Targeting Manganese Dioxide Nanoparticles Coated with the Human Umbilical Cord Mesenchymal Stem Cell Membrane for Cancer Cell Therapy
Xie, L., Zhang, C., Liu, M., Huang, J., Jin, X., Zhu, C., Lv, M., Yang, N., Chen, S., Shao, M., et al. (2023) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.3c01176 · Cited by 62
Targets of tumor microenvironment for potential drug development
Zhang, L., Wang, Z., Liu, K., Liu, Y., Wang, S., Jiang, W., Lu, F., & Dang, Y. (2024) · MedComm – Oncology · doi:10.1002/mog2.68 · Cited by 68
Multiple Mechanisms Involving in Radioresistance of Nasopharyngeal Carcinoma
Zhan, Y., & Fan, S. (2020) · Journal of Cancer · doi:10.7150/jca.39354 · Cited by 61
Graphene-based multifunctional nanosystems for simultaneous detection and treatment of breast cancer
Dolatkhah, M., Hashemzadeh, N., Barar, J., Adibkia, K., Aghanejad, A., Barzegar-Jalali, M., & Omidi, Y. (2020) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2020.111104 · Cited by 62
Cathepsin B-responsive nanodrug delivery systems for precise diagnosis and targeted therapy of malignant tumors
Li, Y., Mei, T., Han, S., Han, T., Sun, Y., Zhang, H., & An, F. (2020) · Chinese Chemical Letters · doi:10.1016/j.cclet.2020.05.027 · Cited by 61
PEGylated carbon dot/MnO2 nanohybrid: a new pH/H2O2-driven, turn-on cancer nanotheranostics
Chen, S., Jia, Q., Zheng, X., Wen, Y., Liu, W., Zhang, H., Ge, J., & Wang, P. (2018) · Science China Materials · doi:10.1007/s40843-018-9261-x · Cited by 61
Immune cell infiltration signatures identified molecular subtypes and underlying mechanisms in gastric cancer
Lin, Y., Pan, X., Zhao, L., Yang, C., Zhang, Z., Wang, B., Gao, Z., Jiang, K., Ye, Y., Wang, S., et al. (2021) · npj Genomic Medicine · doi:10.1038/s41525-021-00249-x · Cited by 61
Luminescent gold nanoclusters for in vivo tumor imaging
Li, H., Li, H., & Wan, A. (2019) · The Analyst · doi:10.1039/c9an01598a · Cited by 60
A novel prognostic signature of immune‐related genes for patients with colorectal cancer
Wang, J., Yu, S., Chen, G., Kang, M., Jin, X., Huang, Y., Lin, L., Wu, D., Wang, L., & Chen, J. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15443 · Cited by 60
Novel pH-Triggered Doxorubicin-Releasing Nanoparticles Self-Assembled by Functionalized β-Cyclodextrin and Amphiphilic Phthalocyanine for Anticancer Therapy
Zheng, K., Liu, X., Liu, H., Dong, D., Li, L., Jiang, L., Huang, M., & Ding, C. (2021) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.0c19027 · Cited by 59
MMP2 and TLRs modulate immune responses in the tumor microenvironment
Muniz-Bongers, L. R., McClain, C. B., Saxena, M., Bongers, G., Mérad, M., & Bhardwaj, N. (2021) · JCI Insight · doi:10.1172/jci.insight.144913 · Cited by 61
Linking Tumor Microenvironment to Plasticity of Cancer Stem Cells: Mechanisms and Application in Cancer Therapy
Zheng, X., Yu, C., & Xu, M. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.678333 · Cited by 63
YKL-40 Derived from Infiltrating Macrophages Collaborates with GDF15 to Establish an Immune Suppressive Microenvironment in Gallbladder Cancer
Wang, Z., Wang, S., Jia, Z., Hu, Y., Cao, D., Yang, M., Liu, L., Gao, L., Qiu, S., Yan, W., et al. (2022) · Cancer Letters · doi:10.1016/j.canlet.2023.216184 · Cited by 60
GLUT1 inhibitor BAY-876 induces apoptosis and enhances anti-cancer effects of bitter receptor agonists in head and neck squamous carcinoma cells
Miller, Z. A., Muthuswami, S., Mueller, A., Ma, R. Z., Sywanycz, S. M., Naik, A., Huang, L., Brody, R. M., Diab, A., Carey, R. M., et al. (2024) · Cell Death Discovery · doi:10.1038/s41420-024-02106-z · Cited by 59
Yes associated protein 1 promotes resistance to 5-fluorouracil in gastric cancer by regulating GLUT3-dependent glycometabolism reprogramming of tumor-associated macrophages
He, Z., Chen, D., Wu, J., Sui, C., Deng, X., Zhang, P., Chen, Z., Liu, D., Yu, J., Shi, J., et al. (2021) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2021.108838 · Cited by 58
Comprehensive insights on pivotal prognostic signature involved in clear cell renal cell carcinoma microenvironment using the ESTIMATE algorithm
Luo, J., Xie, Y., Zheng, Y., Wang, C., Qi, F., Hu, J., & Xu, Y. (2020) · Cancer Medicine · doi:10.1002/cam4.2983 · Cited by 58
Multifaceted Roles of Copper Ions in Anticancer Nanomedicine
Yang, S., Song, Y., Hu, Y., Chen, H., Yang, D., & Song, X. (2023) · Advanced Healthcare Materials · doi:10.1002/adhm.202300410 · Cited by 58
The role of tumor-associated macrophages in lung cancer: From mechanism to small molecule therapy
Zhou, Y., Qian, M., Li, J., Ruan, L., Wang, Y., Cai, C., Gu, S., & Zhao, X. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.116014 · Cited by 57
For and against tumor microenvironment: Nanoparticle-based strategies for active cancer therapy
Karimi, S., Bakhshali, R., Bolandi, S., Zahed, Z., Zadeh, S. S. M., Zenjanab, M. K., & Jahanban‐Esfahlan, R. (2025) · Materials Today Bio · doi:10.1016/j.mtbio.2025.101626 · Cited by 60
Portrait of a CAF: The story of cancer-associated fibroblasts in head and neck cancer
Custódio, M., Biddle, A., & Tavassoli, M. (2020) · Oral Oncology · doi:10.1016/j.oraloncology.2020.104972 · Cited by 60
Recent advances in microfluidic technology and applications for anti-cancer drug screening
Shi, Y., Cai, Y., Cao, Y., Hong, Z., & Chai, Y. (2020) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2020.116118 · Cited by 60
The tumor microenvironment shapes the molecular characteristics of exhausted CD8+ T cells
Cheng, H., Ma, K., Zhang, L., & Li, G. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.02.013 · Cited by 60
Metal ions/nucleotide coordinated nanoparticles comprehensively suppress tumor by synergizing ferroptosis with energy metabolism interference
Wang, Y., Chen, J., Lu, J., Xi, J., Xu, Z., Fan, L., Dai, H., & Gao, L. (2022) · Journal of Nanobiotechnology · doi:10.1186/s12951-022-01405-w · Cited by 57
Effects of helicobacter pylori on tumor microenvironment and immunotherapy responses
Deng, R., Zheng, H., Cai, H., Li, M., Shi, Y., & Ding, S. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.923477 · Cited by 58
Lactate activates CCL18 expression via H3K18 lactylation in macrophages to promote tumorigenesis of ovarian cancer
Sun, J., Feng, Q., He, Y., Wang, M., & Wu, Y. (2024) · Acta Biochimica et Biophysica Sinica · doi:10.3724/abbs.2024111 · Cited by 62
Naproxen platinum( iv ) hybrids inhibiting cycloxygenases and matrix metalloproteinases and causing DNA damage: synthesis and biological evaluation as antitumor agents in vitro and in vivo
Chen, Y., Wang, Q., Li, Z., Liu, Z., Zhao, Y., Zhang, J., Liu, M., Wang, Z., Li, D., & Han, J. (2020) · Dalton Transactions · doi:10.1039/d0dt00424c · Cited by 56
Heterogeneity of cancer-associated fibroblasts in head and neck squamous cell carcinoma: opportunities and challenges
Chen, H., Zhang, Y., Wu, C., & Huang, Q. (2023) · Cell Death Discovery · doi:10.1038/s41420-023-01428-8 · Cited by 63
The role of tumor microenvironment on cancer stem cell fate in solid tumors
Razi, S., Haghparast, A., Khameneh, S. C., Sadrabadi, A. E., Aziziyan, F., Bakhtiyari, M., Nabi‐Afjadi, M., Tarhriz, V., Jalili, A., & Zalpoor, H. (2023) · Cell Communication and Signaling · doi:10.1186/s12964-023-01129-w · Cited by 56
Tumour Microenvironment in Skin Carcinogenesis
Georgescu, S. R., Tampa, M. Ş., Mitran, C. I., Mitran, M. I., Căruntu, C., Căruntu, A., Lupu, M., Matei, C., Constantin, C., & Neagu, M. T. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-36214-0_10 · Cited by 55
Explaining the unexplainable: discrepancies in results from the CALGB/SWOG 80405 and FIRE-3 studies
Aderka, D., Stintzing, S., & Heinemann, V. (2019) · The Lancet Oncology · doi:10.1016/s1470-2045(19)30172-x · Cited by 55
Modulating the blood–brain tumor barrier for improving drug delivery efficiency and efficacy
Song, Y., Hu, C., Fu, Y. S., & Gao, H. (2022) · Open Research (University of Surrey) · doi:10.1002/viw.20200129 · Cited by 54
Integrated analysis of single-cell and bulk RNA-sequencing identifies a signature based on B cell marker genes to predict prognosis and immunotherapy response in lung adenocarcinoma
Song, P., Li, W., Wu, X., Qian, Z., Ying, J., Gao, S., & He, J. (2022) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-022-03143-2 · Cited by 54

Authors: Wu, T., & Dai, Y.
Affiliations: Peking University First Hospital (CN)
Corresponding author: Dai, Yun
ORCID: Wu, Ting
Dai, Yun
Venue: Cancer Letters
Publisher: Elsevier BV
Published: 2017-02
Volume: 387
Pages: 61-68
ISSN: 0304-3835 (ISSN-L)
DOI: 10.1016/j.canlet.2016.01.043
OpenAlex: W2265419075
Cited by: 1,802
References: 124
Citations by year: 2026: 76 · 2025: 179 · 2024: 238 · 2023: 344 · 2022: 382 · 2021: 316 · 2020: 191 · 2019: 48 · 2018: 20 · 2017: 5
FWCI: 2.55
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Cancer Letters (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
Keywords: tumor microenvironment, treatment resistance, drug resistance, stromal fibroblasts, extracellular matrix, cell adhesion, immune cells, immune reprogramming, combination therapy, soluble factors
MeSH terms: Animals, Antineoplastic Agents, Humans, Neoplasms, Molecular Targeted Therapy, Tumor Microenvironment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Tumor microenvironment and therapeutic response

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks